Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
about
Classics in Chemical Neuroscience: Aripiprazole.Pimavanserin, a serotonin(2A) receptor inverse agonist, for the treatment of parkinson's disease psychosis.New concepts in dopamine receptor plasticity.Mechanisms of action of antipsychotic drugs of different classes, refractoriness to therapeutic effects of classical neuroleptics, and individual variation in sensitivity to their actions: Part I.Validity of model approximations for receptor-ligand kinetics in nuclear medicine.
P2860
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@en
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@nl
type
label
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@en
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@nl
prefLabel
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@en
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@nl
P2093
P1476
Central D1- and D2-receptor occupancy during antipsychotic drug treatment.
@en
P2093
P304
P356
10.1016/0278-5846(90)90046-J
P577
1990-01-01T00:00:00Z